Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$63,380.00
Jan 1, 2027
For-profit organization
UK Biomanufacturing - 10143578 - NPmsDNA2024 - Development of in vivo targeted non-viral gene therapies
1034675
As part of the international consortium project “UK Biomanufacturing - 10143578 - NPmsDNA2024 - Development of in vivo targeted non-viral gene therapies”, this project's objective is to use Chromatin Bio's bioinformatics platform to design novel gene regulatory elements, improving gene expression in Mediphage therapeutic constructs for Stargardt disease, while reducing sequence complexity and increasing manufacturing yields. Once generated, these constructs will be complexed with Entos proprietary ocular nanocarrier for in vivo evaluation by NRC and Entos. The best performing candidates will then be manufactured as msDNA drug substances for further therapeutic development.
$10,233.00
Oct 24, 2024
For-profit organization
CIIP PDA – Mediphage Bioceuticals, Inc. – 2024-25
7463390 P015368001
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$75,000.00
Feb 1, 2023
For-profit organization
Linear Covalently Closed DNA Ministring (msDNA) Product and Production Process Development
1001542
This project will optimize the ministring DNA™ (msDNA™) production process to improve yield and purity while also making the process more stable, robust, and resistant to supply chain disruption, while also making the materials safer in the eyes of regulatory agencies by eliminating antibiotic usage from upstream production. Additionally, this project will evaluate next generation msDNA™ constructs to improve the therapeutic effectiveness of the drug substance. In summary, the outcomes of this project will improve the msDNA™ product, the production process, and facilitate the smooth and rapid transition to large-scale production to support Mediphage's genetic medicine program.
$16,257.00
Dec 20, 2020
For-profit organization
Innovation Assistance Program – Round 2.5
966533
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$43,278.00
Jun 25, 2020
For-profit organization
Innovation Assistance Program – Round 2
959858
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support
$30,492.00
Apr 1, 2020
For-profit organization
Innovation Assistance Program
950320
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
$125,000.00
Jul 15, 2019
For-profit organization
Scale-up and Optimization of Linear Covalently Closed DNA Ministrings (msDNA) Production
933784
This project will enable large-scale production of ministring DNA transgene delivery vector by improving fermentation and purification efficiency. Increased production capacity will support Mediphage's genetic medicine program.